Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2017 | Tracking an immunoscore throughout treatment

An immunoscore is an evaluative test of a cancer patient’s adaptive immune activity towards their tumor, and can predict survival, recurrence and treatment response. Here, Jerome Galon, PhD, of Cordeliers Research Center, Paris, France, describes how the immunoscore could be used on tumor biopsies before, during and after a course of treatment to evaluate the efficacy of the therapy and monitor the patient’s wellbeing. This video was recorded at the 2017 National Cancer Research Institute (NCRI) Conference, held in Liverpool, UK.